XML 64 R53.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Feb. 01, 2022
Mar. 17, 2021
Feb. 24, 2021
Feb. 11, 2021
Jan. 25, 2021
Nov. 22, 2020
Sep. 25, 2020
Jul. 21, 2020
Feb. 05, 2020
Feb. 28, 2021
Dec. 31, 2020
Dec. 31, 2022
Dec. 31, 2021
Jul. 22, 2020
Jul. 08, 2020
Jun. 19, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Common stock, par value                       $ 0.0001 $ 0.0001      
Offering price                       $ 0.84        
Shares issued for exercised stock options                         $ 1,506,999      
Preferred stock, shares authorized                       20,000,000 20,000,000      
Warrant exercise price                     $ 8.03 $ 7.30 $ 7.37      
Warrants outstanding                     3,501,014 6,106,023 6,108,823      
Share based compensation expenses                       $ 1,240,129 $ 7,556,282      
Series H Preferred Stock [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Preferred stock stated value                       $ 154.00        
Convertible conversion price increase                       $ 184.80        
Series H Preferred Stock [Member] | Affiliates [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Aggregate issued and outstanding shares percentage                       9.99%        
Series H-3 Preferred Stock [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Preferred stock stated value                       $ 138.00        
Series H-3 Preferred Stock [Member] | Affiliates [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Aggregate issued and outstanding shares percentage                       9.99%        
Series H-6 Convertible Preferred Stock [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Preferred stock stated value                 $ 72.00              
Convertible conversion price increase                 $ 3.60     $ 3.60        
Preferred stock, shares authorized                 50,000              
Preferred stock, conversion price description                 Each share of Series H-6 Preferred Stock is convertible at any time at the option of the holder thereof, into a number of shares of common stock of the Company determined by dividing the H-6 Stated Value by the initial conversion price of $3.60 per share, which was then further reduced to $2.50 under the anti-dilution adjustment provision, subject to a 9.99% blocker provision.              
Series H-6 Convertible Preferred Stock [Member] | Affiliates [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Aggregate issued and outstanding shares percentage                 9.99%              
Common Stock [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Shares issued for exercised stock options, shares                       555,004      
Shares issued for exercised stock options                         $ 55      
Preferred Stock [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Reverse stock split, description                       Upon closing of the Merger, the Company assumed the Series H, H-3 and H-6 preferred stock of DropCar, Inc., which respective conversion prices have been adjusted to reflect the May 2020 one-for-five reverse split.        
Preferred stock, shares authorized                       8,472,500        
Conversion of stock shares                       7,360,985        
Conversion of stock shares issued                       2,007,193        
Securities Purchase Agreement [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Proceeds from sale of common stock         $ 20,000,000.0     $ 1,512,500                
Shares issued for exercised stock options, shares                         555,004      
Shares issued for exercised stock options                   $ 100,000     $ 1,506,999      
Warrants to purchase common stock         233,334             3,566,668        
Warrant exercise price         $ 6.93                      
Securities Purchase Agreement [Member] | Investor [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Number of additional shares purchased               302,500                
Securities Purchase Agreement [Member] | Additional Shares [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Number of shares issued       4,400,001                        
Common stock, par value       $ 0.0001 0.0001     $ 0.0001                
Offering price       $ 9.50 $ 6.00     $ 5.00                
Proceeds from sale of common stock       $ 41,800,008                        
Offering expenses       $ 3,394,054                        
Purchase of additional shares description   (i) sell up to 5% of such stockholder’s holdings in the Company’s common stock on any trading day (with such 5% limitation to be measured as of the date of each sale) and (ii) allow for unlimited sales of the Company’s common stock for any sales made at $10.00 per share or greater.   Each purchaser was also granted an option to purchase, on or before February 16, 2022, additional shares of common stock equal to the full amount of 75% of the common stock it purchased at the initial closing, or an aggregate of 3,300,001 shares, at an exercise price of $11.50 per share.                        
Securities Purchase Agreement [Member] | Additional Shares [Member] | Investor [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Number of shares issued       3,300,001                        
Offering price       $ 11.50                        
Securities Purchase Agreement [Member] | Warrant [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Shares issued for exercised stock options, shares                   13,642            
January 2021 Offering [Member] | Securities Purchase Agreement [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Number of shares issued         3,333,334                      
Warrant exercise price         $ 6.93                      
January 2021 Offering [Member] | Securities Purchase Agreement [Member] | Additional Shares [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Number of shares issued         3,333,334                      
Common stock, par value         $ 0.0001                      
Offering price         $ 6.00                      
Proceeds from sale of common stock         $ 20,000,004                      
Offering expenses         $ 1,648,608                      
Restricted Stock [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Number of shares vested                       374,686 1,158,891      
Restricted Stock [Member] | Director [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Number of restricted shares 442,248                              
Share price $ 1.29                              
Restricted Stock [Member] | Director [Member] | 2020 Long-Term Incentive Plan [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Number of restricted shares 442,249   172,000                          
Share price $ 1.29   $ 7.66                          
Number of restricted shares issued and vested                       331,686        
Restricted Stock [Member] | Common Stock [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Common Stock, Shares Subscribed but Unissued                         43,000      
Series H-3 Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Conversion price per share                       $ 165.60        
Warrants to purchase common stock                       2,800        
Warrant exercise price                       $ 165.60        
Warrants outstanding                       2,800        
Warrants and rights outstanding term                       5 years        
Seed Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock                       461,647        
Warrant exercise price                       $ 7.33        
Warrants outstanding                       448,005        
Series I Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock                       14,636        
Warrant exercise price                       $ 69.00        
Warrants outstanding                         14,636      
Warrants description                       If at any time (i) the volume weighted average price (“VWAP”) of the Common Stock exceeds $138.00 for not less than the mandatory exercise measuring period; (ii) the daily average number of shares of Common Stock traded during the mandatory exercise measuring period equals or exceeds 25,000; and (iii) no equity conditions failure has occurred as of such date, then the Company shall have the right to require the holder to exercise all or any portion of the Series I Warrants still unexercised for a cash exercise.        
Warrant weighted average exercise price                       $ 138.00        
Series H-4 Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrant exercise price                       $ 15.60        
Warrants outstanding                       37,453        
Anti-dilution price protection price per share                       $ 15.60        
Series J Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock                       52,023        
Warrant exercise price                       $ 30.00        
Warrants outstanding                       52,023        
Warrants description                       If at any time (i) the VWAP of the Common Stock exceeds $9.00 for not less than the mandatory exercise measuring period; (ii) the daily average number of shares of Common Stock traded during the mandatory exercise measuring period equals or exceeds 25,000; and (iii) no equity conditions failure has occurred as of such date, then the Company shall have the right to require the holder to exercise all or any portion of the Series J Warrants still unexercised for a cash exercise.        
Exceeds warrant price per share                       $ 45.00        
Series H-5 Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock                       296,389        
Warrant exercise price                       $ 2.50        
Warrants outstanding                       348,476        
Warrants description                       The H-5 Warrants are entitled to certain anti-dilution adjustments if the Company issues shares of its common stock at a lower price per share than the applicable exercise price (subject to a floor of $0.792 per share). An anti-dilution adjustment was triggered resulting in an adjusted exercise price per share from $3.96 to $2.50, resulting in an issuance of an additional 173,091 warrants that are exercisable at $2.50 per share.        
Warrants and rights outstanding term                       5 years        
Series H-5 Warrants [Member] | Minimum [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrant exercise price                       $ 3.96        
Series H-5 Warrants [Member] | Maximum [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrant exercise price                       $ 2.50        
Number of warrants issued                       173,091        
June Finder Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock                               27,273
Warrant exercise price                               $ 2.75
Warrants outstanding                       27,273        
Warrants and rights outstanding term                               5 years
June Placement Agent Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock                     126,000         126,000
Warrant exercise price                               $ 2.875
July 8 Finder Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock                       71,770     71,770  
Warrant exercise price                             $ 5.225  
July 8 Placement Agent Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock                       147,368     147,368  
Warrant exercise price                             $ 5.4625  
Warrants and rights outstanding term                             5 years  
July 22 Placement Agent Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock                       129,500   129,500    
Warrant exercise price                           $ 5.750    
Warrants and rights outstanding term                           5 years    
September Warrant [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock             31,348         31,348        
Warrant exercise price             $ 3.19                  
Warrant expiration description             The September Warrant is immediately exercisable and expires on September 25, 2025.                  
Decrease in exercise price             $ 2.13                  
Share based compensation expenses                     $ 66,845          
Series A Warrants and Series B [Member] | Securities Purchase Agreement [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Value of common stock issued           $ 9,999,997                    
Series A Warrants [Member] | Securities Purchase Agreement [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock           1,237,624           0        
Warrant exercise price           $ 8.09                    
Warrant expiration date           May 24, 2021                    
Series B Warrants [Member] | Securities Purchase Agreement [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock           825,084           825,084        
Warrant exercise price           $ 8.90                    
November Finder Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock           56,256                    
Warrant exercise price           $ 6.6660                    
November Placement Agent Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock           57,756                    
Warrant exercise price           $ 6.9690                    
Warrants description           The November Finder Warrants and November Placement Agent Warrants terminate after a period of 5 years on November 22, 2025.                    
February Finder Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock       15,574               51,459        
Warrant exercise price       $ 10.925                        
February Finder Warrants [Member] | Common Stock [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock       35,885                        
Warrant exercise price       $ 10.45                        
February Placement Agent Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock       255,584               255,584        
Warrants and rights outstanding term       5 years